Conference call to begin at 4:30 p.m. ET
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2024 after the market close on Monday, May 13, 2024. The Vaxart senior management team will host a conference call on the same day, beginning at 4:30 p.m. ET.
The conference call can be accessed using the following information:
Webcast: Click here
Date: Monday, May 13, 2024 – 4:30 p.m. ET
Domestic: (877) 407-0832
International: (201) 689-8433
Conference ID: 13745591
Investors may submit written questions in advance of the conference call to ir@vaxart.com.
A replay of the webcast will be available on the Company’s website at www.vaxart.com following the conclusion of the event.
About Vaxart
Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart’s development programs currently include pill vaccines designed to protect against coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart’s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.
Contacts | ||
Vaxart Media Relations: Mark Herr Vaxart, Inc. mherr@vaxart.com (203) 517-8957 |
Investor Relations: Andrew Blazier FINN Partners IR@vaxart.com (646) 871-8486 |
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body…
NEW YORK--(BUSINESS WIRE)--Surgimate, a leading provider of surgical coordination and scheduling software in the U.S.,…
Industry vendors team up to support radiation oncology clinics nationwide BOONE, N.C., June 19, 2025…
CLEVELAND, June 19, 2025 /PRNewswire/ -- PartsSource, the leading technology and enterprise software platform for…
Tenured healthcare executive to succeed Founder Elisabete Miranda Smith to build on 25-year legacy of…